Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2012
05/30/2012EP2457559A1 Method for producing salt dust and salt dust generator
05/30/2012EP2457451A1 Delivery and controlled release of encapsulated lopophilic nutrients
05/30/2012EP2456868A1 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
05/30/2012EP2456839A1 Process for the continuous manufacture of a polyisobutylene based transdermal patch
05/30/2012EP2456468A1 Fas (apo-1, cd95) targeted platforms for intracellular drug delivery
05/30/2012EP2456448A1 Methods of attenuating the loss of functional status
05/30/2012EP2456439A2 A stable pharmaceutical omeprazole formulation for oral administration
05/30/2012EP2456430A1 Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemia
05/30/2012EP2456427A1 Hot-melt extruded controlled release dosage form
05/30/2012EP2456426A1 Ferric citrate dosage forms
05/30/2012EP2456425A1 Tamper-resistant dosage form for oxidation-sensitive opioids
05/30/2012EP2456424A1 Oxidation-stabilized tamper-resistant dosage form
05/30/2012EP2456423A2 Treatment of hyperproliferative conditions
05/30/2012EP2456422A2 Topical pharmaceutical composition including rel-n-[6-[(2r,6s)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-41-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide.
05/30/2012EP2456421A1 Multi-layered gradient vaginal ring
05/30/2012EP2456409A1 Natural preservative blend
05/30/2012EP2456306A1 Vitamin c and vitamin k, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant
05/30/2012EP2021002B1 Pharmaceutical composition comprising olmesartan medoxomil
05/30/2012EP1843783B1 Control of drug release by transient modification of local microenvironments
05/30/2012EP1761245B1 Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom
05/30/2012EP1744764B1 Liposomal formulations of anthracycline agents and cytidine analogs
05/30/2012EP1682116B1 Method for preparing submicron particles of paclitaxel or docetaxel
05/30/2012EP1372619B1 Process for the production of a highly flexible transdermal therapeutic system having nicotine as active substance
05/30/2012EP1178808B1 Non-aqueous pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin d, a corticosteroid and a solvent component
05/30/2012CN202236455U Chinese medicinal powder for treating spleen channel tissue disease and package
05/30/2012CN202236453U Traditional Chinese medicine soup for treating gallbladder and liver tissue diseases and package thereof
05/30/2012CN202236452U Traditional Chinese medicine soup for treating gallbladder and heart tissue diseases and package thereof
05/30/2012CN202236450U Traditional Chinese medicine slurry and package combination for treating complications of tissues of small intestine and stomach channels
05/30/2012CN202236449U Traditional Chinese medicine soup for treating small intestine and stomach tissue diseases and package thereof
05/30/2012CN202236448U Chinese medicine powder for treating combined small intestine and lung tissue diseases and packages thereof
05/30/2012CN202236446U Traditional Chinese medicine decotion and package for treatment of associated small intestine and lung meridian diseases
05/30/2012CN202236445U Chinese medicine powder for treating liver tissue diseases and packages thereof
05/30/2012CN202236444U Traditional Chinese medicinal powder for treating tissue disease of urinary bladder channel and packages
05/30/2012CN202236442U Traditional Chinese medicine decoction for treating bladder meridian tissue diseases and package thereof
05/30/2012CN202236441U Traditional Chinese medicine soup for treating heart tissue diseases and package thereof
05/30/2012CN202236440U Traditional Chinese medicine soup for treating lung channel tissue diseases and packaging
05/30/2012CN202236439U Traditional Chinese medicine soup for treating liver tissue diseases and package thereof
05/30/2012CN202236438U Externally-applied plaster for treating pharyngitis
05/30/2012CN202236437U Traditional Chinese medicine slurry and package combination for treating diseases of kidney channel tissues
05/30/2012CN202236436U Soporific patch
05/30/2012CN202236435U Tissue soaked with medicine for treating tinea pedis
05/30/2012CN202236433U Blumea riparia tablet
05/30/2012CN202236432U Prostatitis paster
05/30/2012CN202236431U Gauze plaster
05/30/2012CN202236430U Medicinal patch for treating onychomycosis
05/30/2012CN202236429U Veterinary tablet capsule with adjustable administration dosage
05/30/2012CN202236428U Veterinary tablet capsule with adjustable administration dosage
05/30/2012CN202236427U Tablet of veterinary medicine
05/30/2012CN202236365U Heath capsule structure
05/30/2012CN1993144B Stable dosing form of phenylalanine derivatives
05/30/2012CN1980643B Method for the production of an abuse-proof, solid form of administration
05/30/2012CN1951367B Fat emulsion containing hydroxycamptothecine and preparation method thereof
05/30/2012CN1903187B Compound isopropyl phenol injection containing local anesthetic and preparation method therefor
05/30/2012CN1726048B Gastric acid secretion inhibiting composition
05/30/2012CN1688275B Process for the production of microspheres
05/30/2012CN1655766B Sustained release of guaifenesin combination drugs
05/30/2012CN1615156B Preparation of resinates
05/30/2012CN1600327B External pasted medication for curing nervus vascularis headache and perparation method of production
05/30/2012CN1562254B Ointement of Chinese traditional medicine for curing hyperosteogeny
05/30/2012CN102482685A 包括多核苷酸剂的细胞靶向纳米颗粒及其应用 Including cell polynucleotide agents targeted nanoparticle and its application
05/30/2012CN102482526A Coating agent comprising hydroxyalkyl cellulose
05/30/2012CN102482506A Spray-dried dye compositions, process for the production and use thereof
05/30/2012CN102482477A 水溶性聚合物组合物、皮肤贴剂的膏体层形成用组合物、及皮肤贴剂 A water-soluble polymer composition, the skin patch paste layer forming composition, and a skin patch
05/30/2012CN102482358A 羟丙基纤维素粒子 Hydroxypropyl cellulose particles
05/30/2012CN102481438A Implantable Drug Delivery Devices And Methods Of Making The Same
05/30/2012CN102481437A Modular ingestible drug delivery capsule
05/30/2012CN102481376A Immunomodulatory agent-polymeric compounds
05/30/2012CN102481375A Nanocarriers possessing components with different rates of release
05/30/2012CN102481374A Nanocarriers possessing components with different rates of release
05/30/2012CN102481370A 聚合物药物传递系统及生产所述系统的方法 Polymeric drug delivery systems and production method of the system
05/30/2012CN102481343A 稳定的含胰岛素的非水液体药物组合物 Stability of the insulin-containing non-aqueous liquid pharmaceutical composition
05/30/2012CN102481322A Bacterial compositions for prophylaxis and treatment of degenerative disease
05/30/2012CN102481315A Antacid And Laxative Tablet
05/30/2012CN102481313A Pharmaceutical Composition For Suppressing Pain
05/30/2012CN102481305A 磷脂酰胆碱的经皮组合物及其制备方法 Phosphatidylcholine percutaneous composition and its preparation method
05/30/2012CN102481301A 含有拉坦前列素的水性滴眼剂以及抑制拉坦前列素对树脂的吸附的方法 The method of water containing latanoprost latanoprost eye drops and inhibit the absorption of resin
05/30/2012CN102481296A 溶解性改善的药用组合物 Improved solubility of the pharmaceutical composition
05/30/2012CN102481293A 治疗具有发展nsaid-相关的溃疡的风险的患者的方法 Treatment of patients with the risk associated with the development of ulcers method nsaid-
05/30/2012CN102481291A 用于治疗、减轻症状、缓解、改善和预防认知疾病、障碍或病症的方法 A method for treating, alleviating the symptoms, alleviating, ameliorating and preventing cognitive disease, disorder, or condition
05/30/2012CN102481290A 用于治疗红斑痤疮或红脸相关皮肤病的含黄连素或其类似物的组合物 Composition for the treatment of rosacea or dermatological cop containing berberine related analogs thereof
05/30/2012CN102481275A Topical composition containing ibuprofen
05/30/2012CN102481264A 包含聚噁唑啉和生物活性剂的药物递送系统 And a medicament comprising polyoxazoline bioactive agent delivery system
05/30/2012CN102481263A Crosslinked protein nanocrystals, crosslinked protein nanoaggregates and method of preparation thereof
05/30/2012CN102481262A 使用蜡状物质的包封 Encapsulated waxy substance use
05/30/2012CN102481261A 药物组合物 The pharmaceutical composition of
05/30/2012CN102481260A 抗干扰的剂型,其包括基质和包含药物的熔融挤出的颗粒 Interference dosage form comprising a drug-containing matrix and the melt extruded particles
05/30/2012CN102481259A 一种药物输送方法 A drug delivery method
05/30/2012CN102481258A 源自固体粉末疏水化合物的薄膜包衣组合物 Film coating compositions derived from the solid powder of the hydrophobic compound
05/30/2012CN102481257A Particulate material for controlled release of active ingredients
05/30/2012CN102481256A 包含亚氨基脂质的两性脂质体 Amphoteric liposomes containing imino liposome
05/30/2012CN102481255A Particle composition and medicinal composition comprising same
05/30/2012CN102481254A Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes
05/30/2012CN102481253A 包含羟基氯喹的用于抗癌治疗的局部投药用注射剂组合物 Hydroxychloroquine comprising topical administration for the treatment of anti-cancer pharmaceutical composition for injection
05/30/2012CN102481252A 含有羟基氯喹的用于痔核治疗的局部投药用注射剂组合物 Hydroxychloroquine containing topical treatment for hemorrhoids vote pharmaceutical composition for injection
05/30/2012CN102481251A Ipamorelin diacetate injection and infusion solutions
05/30/2012CN102481250A 舌下和口腔膜组合物 Sublingual and oral film composition
05/30/2012CN102481249A 包含相对构型-n-[6-[(2r,6s)-2,6-二甲基-4-吗啉基]-3-吡啶基]-2-甲基-4'-(三氟甲氧基)-[1,1'-联苯]-3-甲酰胺的局部药物组合物 Contains the relative configuration -n- [6 - [(2r, 6s) -2,6- dimethyl-4-morpholinyl] -3-pyridinyl] -2-methyl-4 '- (trifluoromethyl oxy) - local drug [1,1'-biphenyl] -3-carboxamide composition
05/30/2012CN102481248A 固体制剂 Solid preparations
05/30/2012CN102481204A Pulsatile release of medicaments from a punctal plug
05/30/2012CN102480987A Process for compressing isomalt